Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mitchell, Charles D
STOMP, NCT05534984: Study of Tecovirimat for Human Mpox Virus	Active, not recruiting	3	719	Japan, US, RoW	Tecovirimat Oral Capsule, Placebo, Tecovirimat Oral Capsule (Open Label)	National Institute of Allergy and Infectious Diseases (NIAID), SIGA Technologies	MPOX	10/24	09/25
NCT05674656 / 2022-000829-24: Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics	Recruiting	1/2	20	US	Dolutegravir/Rilpivirine FDC, JULUCA	ViiV Healthcare, Janssen Research & Development, LLC	HIV Infections	06/26	05/28
Bryan, Patricia
NCT05523596: A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults	Active, not recruiting	1	13	US	ICM20, Benznidazole	IC-MedTech Corporation	Safety Issues	12/24	03/27